Coda Closes $7M VC Round, Will Use Cash for Biofuel Initiative and Rx Demo | GenomeWeb
NEW YORK (GenomeWeb News) — Coda Genomics has pocketed a $7 million Series C round of private equity financing and plans to use the cash to fund and manage growth, particularly in its collaborations with pharmaceutical companies, the company said today.
Coda CEO Robert Molinari said the financing will push growth in “several opportunistic areas,” including translational engineering, funding a biofuel enzyme initiative with the University of California, Irvine, and developing a therapeutic candidate demonstration project.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.

Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.

According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.

National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.